Reuters Pharma USA 2024 - Day 1

Market Access
Reuters Pharma USA 2024 Day 1

Tuesday at Reuters Pharma USA kicks off with morning keynotes focused on innovation, transformation, and patient experience.

We’ll hear from executives at GSK, Biogen, Takeda, and Genentech, as well as tech giants like Oracle. Then, in the afternoon we’ll check in on the Market Access track and hear from UCB and Bristol-Myers Squibb about the ongoing impacts of the US Inflation Reduction Act. After a break for some video interviews, we’ll wrap the day up with some little tastes of AI and cell and gene therapy content.

So, keep checking back throughout the day to follow the hottest conversations in pharma!